Replies to post #346102 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

it is ludicrous to say that it would not be possible for little IPIX to contract enough production to meet the worldwide demand. That assertion is literally ridiculous.

It's the timeliness factor not whether it can be done eventually or not. If you're adamant that IPIX can do it as fast as Gilead or Merck...fine...you believe what you want. $250M/month was spent on Remdesivir last year. You really want to chance delays because someone didn't know what they were doing when dealing with that kind of money? Do you know what $30M/month on one indication in revenues would do for our company?

It doesn't change reality. You wait and see. If Brilacidin makes it through the phase 2, we will partner to bring it to market and the royalty percentage with be <30%. And that will be the right move.

Go IPIX!